|
ITGAV expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.408100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.176000E-04 |
| Normal-vs-Stage2 |
7.307200E-01 |
| Normal-vs-Stage3 |
2.939800E-03 |
| Normal-vs-Stage4 |
1.649010E-01 |
| Stage1-vs-Stage2 |
8.981000E-03 |
| Stage1-vs-Stage3 |
6.989000E-01 |
| Stage1-vs-Stage4 |
1.823650E-01 |
| Stage2-vs-Stage3 |
6.761300E-03 |
| Stage2-vs-Stage4 |
1.519630E-01 |
| Stage3-vs-Stage4 |
1.653000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.633360E-04 |
| Normal-vs-AfricanAmerican |
6.713800E-02 |
| Normal-vs-Asian |
8.046400E-02 |
| Caucasian-vs-AfricanAmerican |
9.567400E-01 |
| Caucasian-vs-Asian |
6.288200E-01 |
| AfricanAmerican-vs-Asian |
7.173000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.112100E-02 |
| Normal-vs-Female |
2.834600E-04 |
| Male-vs-Female |
1.355620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.83500000000248E-05 |
| Normal-vs-Age(41-60Yrs) |
1.334490E-02 |
| Normal-vs-Age(61-80Yrs) |
1.783640E-01 |
| Normal-vs-Age(81-100Yrs) |
4.284200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.172500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.012100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.258200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.048600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.738600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.817800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.057410E-01 |
| Classical-VS-Follicular |
7.56380513777799E-11 |
| Classical-VS-Other |
2.628200E-01 |
| Classical-VS-Normal |
3.12319999995481E-06 |
| Tall-VS-Follicular |
3.64729999999813E-05 |
| Tall-VS-Other |
1.021230E-01 |
| Tall-VS-Normal |
7.614400E-04 |
| Follicular-VS-Other |
3.552000E-01 |
| Follicular-VS-Normal |
6.299700E-02 |
| Other-VS-Normal |
8.103400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.581600E-01 |
| Normal-vs-N1 |
2.281800E-02 |
| N0-vs-N1 |
6.093900E-02 |
|
|
